# A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated

> **NCT04866160** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 1291583
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04866160
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-17
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04866160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04866160, "A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04866160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*